These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 26638889
1. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells. Zhang H, Wang X, Chen Z, Wang W. Cell Mol Biol (Noisy-le-grand); 2015 Nov 30; 61(7):96-101. PubMed ID: 26638889 [Abstract] [Full Text] [Related]
2. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Vivacqua A, Romeo E, De Marco P, De Francesco EM, Abonante S, Maggiolini M. Breast Cancer Res Treat; 2012 Jun 30; 133(3):1025-35. PubMed ID: 22147081 [Abstract] [Full Text] [Related]
3. [Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells]. Guo RX, Lei J, Wang XY, Ge X, Hu DM, Ma XY, Li LX, Qiao YH. Zhonghua Fu Chan Ke Za Zhi; 2013 Feb 30; 48(2):129-33. PubMed ID: 23544495 [Abstract] [Full Text] [Related]
4. MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma. Deng J, Wang W, Yu G, Ma X. Mol Med Rep; 2019 Nov 30; 20(5):4023-4032. PubMed ID: 31545414 [Abstract] [Full Text] [Related]
5. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer. Tao S, He H, Chen Q, Yue W. Biochem Biophys Res Commun; 2014 Aug 15; 451(1):74-8. PubMed ID: 25063027 [Abstract] [Full Text] [Related]
6. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells. Ge X, Guo R, Qiao Y, Zhang Y, Lei J, Wang X, Li L, Hu D. Int J Gynecol Cancer; 2013 Jan 15; 23(1):52-9. PubMed ID: 23235274 [Abstract] [Full Text] [Related]
7. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y. Oncol Rep; 2012 Feb 15; 27(2):504-10. PubMed ID: 22075757 [Abstract] [Full Text] [Related]
8. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1. Chen C, Wang Y, Wang S, Liu Y, Zhang J, Xu Y, Zhang Z, Bao W, Wu S. Int J Oncol; 2017 Mar 15; 50(3):942-952. PubMed ID: 28098854 [Abstract] [Full Text] [Related]
9. TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation. Xie BY, Lv QY, Ning CC, Yang BY, Shan WW, Cheng YL, Gu C, Luo XZ, Zhang ZB, Chen XJ, Xi XW, Feng YJ. Biochem Biophys Res Commun; 2017 Jan 22; 482(4):857-862. PubMed ID: 27889612 [Abstract] [Full Text] [Related]
10. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro. Fan DX, Yang XH, Li YN, Guo L. Med Sci Monit; 2018 Apr 02; 24():1936-1947. PubMed ID: 29608013 [Abstract] [Full Text] [Related]
11. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells. Yu T, Liu M, Luo H, Wu C, Tang X, Tang S, Hu P, Yan Y, Wang Z, Tu G. J Steroid Biochem Mol Biol; 2014 Sep 02; 143():392-403. PubMed ID: 24874276 [Abstract] [Full Text] [Related]
12. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1. Li Y, Jia Y, Bian Y, Tong H, Qu J, Wang K, Wan XP. Cell Commun Signal; 2019 Mar 05; 17(1):22. PubMed ID: 30836961 [Abstract] [Full Text] [Related]
13. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs). Vivacqua A, De Marco P, Santolla MF, Cirillo F, Pellegrino M, Panno ML, Abonante S, Maggiolini M. Oncotarget; 2015 Jun 30; 6(18):16573-87. PubMed ID: 26030000 [Abstract] [Full Text] [Related]
14. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1. Liu C, Liao Y, Fan S, Tang H, Jiang Z, Zhou B, Xiong J, Zhou S, Zou M, Wang J. Med Oncol; 2015 Apr 30; 32(4):104. PubMed ID: 25744245 [Abstract] [Full Text] [Related]
15. Role of miR-203 in estrogen receptor-mediated signaling in the rat uterus and endometrial carcinoma. Zierau O, Helle J, Schadyew S, Morgenroth Y, Bentler M, Hennig A, Chittur S, Tenniswood M, Kretzschmar G. J Cell Biochem; 2018 Jul 30; 119(7):5359-5372. PubMed ID: 29331043 [Abstract] [Full Text] [Related]
16. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M. Mol Endocrinol; 2006 Mar 30; 20(3):631-46. PubMed ID: 16239258 [Abstract] [Full Text] [Related]
17. [Effect of GPER on the activation of PI3K/Akt induced by 17β-estradiol in endometrial carcinoma cells]. Zhang YC, Guo RX, Ge X, Qiao YH. Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 30; 47(4):292-6. PubMed ID: 22781117 [Abstract] [Full Text] [Related]
18. 17β-estradiol protects INS-1 insulinoma cells from mitophagy via G protein-coupled estrogen receptors and the PI3K/Akt signaling pathway. Zhang L, Zhao Y, Guo L. Int J Mol Med; 2018 May 30; 41(5):2839-2846. PubMed ID: 29436590 [Abstract] [Full Text] [Related]